WFG Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$601K Buy
4,819
+4,809
+48,090% +$570K 0.14% 175
2017
Q1
$1K Sell
10
-2,200
-100% -$249K ﹤0.01% 1443
2016
Q4
$221K Buy
2,210
+117
+6% +$12.5K 0.05% 354
2016
Q3
$264K Buy
2,093
+36
+2% +$4.45K 0.07% 301
2016
Q2
$240K Buy
2,057
+2,047
+20,470% +$232K 0.06% 288
2016
Q1
$1K Hold
10
﹤0.01% 1468
2015
Q4
$1K Hold
10
﹤0.01% 1504
2015
Q3
$1K Sell
10
-31
-76% -$3.11K ﹤0.01% 1537
2015
Q2
$4K Sell
41
-28
-41% -$3.1K ﹤0.01% 1399
2015
Q1
$8K Sell
69
-281
-80% -$32.1K ﹤0.01% 1270
2014
Q4
$39K Hold
350
0.01% 985
2014
Q3
$34K Buy
350
+29
+9% +$2.85K 0.01% 1059
2014
Q2
$32K Hold
321
0.01% 1086
2014
Q1
$30K Sell
321
-194
-38% -$17.9K 0.01% 1102
2013
Q4
$47K Sell
515
-103
-17% -$8.91K 0.01% 1021
2013
Q3
$49K Buy
618
+63
+11% +$4.96K 0.01% 938
2013
Q2
$40K Buy
+555
New +$41.5K 0.01% 974

Other funds holding ZBH

WFG Advisors's ZBH Position: Q2 2017 in Review

WFG Advisors increased its Zimmer Biomet (ZBH) stake by 48,090% in Q2 2017, buying an estimated $570K and bringing the position to 4,819 shares worth $601K. The position accounts for 0.14% of the portfolio, ranked #175.

WFG Advisors first reported a position in ZBH in Q2 2013 and has held it in 17 quarters since. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

  • WFG Advisors held 4,819 shares of Zimmer Biomet worth $601K as of Q2 2017.
  • WFG Advisors bought 4,809 Zimmer Biomet shares in Q2 2017, an estimated $570K.
  • Zimmer Biomet made up 0.14% of WFG Advisors's portfolio in Q2 2017, its #175 holding.
  • WFG Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 17 quarters since.
  • 819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.